血管紧张素抑制剂对心力衰竭合并肾性贫血患者肌酐和血红蛋白的影响(3)
[7]Sturgill J， Howell S， Perry MM， et al. Protocols for treating patients with end-stage renal disease： a survey of undergraduate dental programs[J]. Spec Care Dentist，2016，36(6)：321-324.
[8]Charytan DM， Solomon SD， Ivanovich P， et al. ESRD after heart failure， myocardial infarction， or stroke in type 2 diabetic patients with CKD[J]. Am J Kidney Dis，2017，70(4)：522-531.
[9]He J， Shlipak M， Anderson A， et al. Risk factors for heart failure in patients with chronic kidney disease： the CRIC (chronic renal insufficiency cohort) study[J]. J Am Heart Assoc，2017，6(5)：e005336.
[10]Pita-Fernández S， Choucino-Fernández T， Juega-Puig J， et al. A randomized clinical trial to determine the effect of angiotensin inhibitors reduction on creatinine clearance and haemoglobin in heart failure patients with chronic kidney disease and anaemia[J]. Int J Clin Pract，2014，68(10)：1231-1238.
[11]Gut N， Piecha G， Aldebssi F， et al. Erythropoietin combined with ACE inhibitor prevents heart remodeling in 5/6 nephrectomized rats independently of blood pressure and kidney function[J]. Am J Nephrol，2013，38(2)：124-135.
[12]Karas MG， Sobol I， Maurer MS， et al. Sex-and race-related differences in characteristics and outcomes of hospitalizations for heart failure with preserved ejection fraction[J]. J Am Heart Assoc，2017，6(4)：e003330.
(收稿日期：2018-10-11), 百拇医药(何文静)
[8]Charytan DM， Solomon SD， Ivanovich P， et al. ESRD after heart failure， myocardial infarction， or stroke in type 2 diabetic patients with CKD[J]. Am J Kidney Dis，2017，70(4)：522-531.
[9]He J， Shlipak M， Anderson A， et al. Risk factors for heart failure in patients with chronic kidney disease： the CRIC (chronic renal insufficiency cohort) study[J]. J Am Heart Assoc，2017，6(5)：e005336.
[10]Pita-Fernández S， Choucino-Fernández T， Juega-Puig J， et al. A randomized clinical trial to determine the effect of angiotensin inhibitors reduction on creatinine clearance and haemoglobin in heart failure patients with chronic kidney disease and anaemia[J]. Int J Clin Pract，2014，68(10)：1231-1238.
[11]Gut N， Piecha G， Aldebssi F， et al. Erythropoietin combined with ACE inhibitor prevents heart remodeling in 5/6 nephrectomized rats independently of blood pressure and kidney function[J]. Am J Nephrol，2013，38(2)：124-135.
[12]Karas MG， Sobol I， Maurer MS， et al. Sex-and race-related differences in characteristics and outcomes of hospitalizations for heart failure with preserved ejection fraction[J]. J Am Heart Assoc，2017，6(4)：e003330.
(收稿日期：2018-10-11), 百拇医药(何文静)